D.E. Shaw & Co
EXAS

D.E. Shaw & Co’s Exact Sciences EXAS Stock Holding History

D.E. Shaw & Co’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-502,142
Closed -$51M – 4684
2025
Q4 		$51M Buy
502,142
+481,379
+2,318% +$38.7M 0.03% 688
2025
Q3 		$1.14M Sell
20,763
-48,231
-70% -$2.41M ﹤0.01% 3382
2025
Q2 		$3.67M Buy
68,994
+7,419
+12% +$377K ﹤0.01% 2263
2025
Q1 		$2.67M Buy
61,575
+28,463
+86% +$1.44M ﹤0.01% 2394
2024
Q4 		$1.86M Sell
33,112
-9,600
-22% -$597K ﹤0.01% 2782
2024
Q3 		$2.91M Buy
42,712
+2,464
+6% +$139K ﹤0.01% 2407
2024
Q2 		$1.7M Sell
40,248
-81,626
-67% -$4.49M ﹤0.01% 2799
2024
Q1 		$8.42M Buy
121,874
+99,127
+436% +$6.27M 0.01% 1490
2023
Q4 		$1.68M Sell
22,747
-146,359
-87% -$9.59M ﹤0.01% 2803
2023
Q3 		$11.5M Buy
169,106
+166,606
+6,664% +$14.1M 0.01% 1193
2023
Q2 		$235K Sell
2,500
-7,419
-75% -$579K ﹤0.01% 3688
2023
Q1 		$673K Sell
9,919
-134,713
-93% -$8.66M ﹤0.01% 3399
2022
Q4 		$7.16M Sell
144,632
-26,643
-16% -$1.09M 0.01% 1753
2022
Q3 		$5.57M Sell
171,275
-13,006
-7% -$536K 0.01% 1964
2022
Q2 		$7.26M Buy
184,281
+137,309
+292% +$7.34M 0.01% 1716
2022
Q1 		$3.28M Sell
46,972
-50,478
-52% -$3.69M ﹤0.01% 2789
2021
Q4 		$7.58M Sell
97,450
-50,068
-34% -$4.42M 0.01% 1944
2021
Q3 		$14.1M Sell
147,518
-60,241
-29% -$6.36M 0.01% 1255
2021
Q2 		$25.8M Sell
207,759
-237,622
-53% -$28.4M 0.02% 872
2021
Q1 		$58.7M Buy
445,381
+207,079
+87% +$28.3M 0.06% 419
2020
Q4 		$31.6M Buy
238,302
+217,319
+1,036% +$26.3M 0.03% 720
2020
Q3 		$2.14M Sell
20,983
-7,206
-26% -$622K ﹤0.01% 2351
2020
Q2 		$2.45M Buy
28,189
+11,348
+67% +$907K ﹤0.01% 2247
2020
Q1 		$977K Sell
16,841
-460,403
-96% -$37.4M ﹤0.01% 2749
2019
Q4 		$44.1M Sell
477,244
-572,155
-55% -$50.3M 0.05% 448
2019
Q3 		$94.8M Sell
1,049,399
-583,763
-36% -$66.5M 0.12% 203
2019
Q2 		$193M Sell
1,633,162
-863,588
-35% -$87M 0.24% 67
2019
Q1 		$216M Buy
2,496,750
+693,159
+38% +$59M 0.28% 64
2018
Q4 		$114M Buy
1,803,591
+521,953
+41% +$35.8M 0.16% 141
2018
Q3 		$101M Sell
1,281,638
-2,055,467
-62% -$134M 0.12% 198
2018
Q2 		$200M Buy
3,337,105
+579,440
+21% +$31.2M 0.26% 70
2018
Q1 		$111M Sell
2,757,665
-638,738
-19% -$31.2M 0.15% 169
2017
Q4 		$178M Sell
3,396,403
-686,815
-17% -$36.7M 0.25% 77
2017
Q3 		$192M Buy
4,083,218
+287,176
+8% +$11.6M 0.3% 61
2017
Q2 		$134M Sell
3,796,042
-80,248
-2% -$2.48M 0.22% 92
2017
Q1 		$91.6M Sell
3,876,290
-785,281
-17% -$15.6M 0.16% 144
2016
Q4 		$62.3M Sell
4,661,571
-785,229
-14% -$12.7M 0.11% 230
2016
Q3 		$101M Buy
5,446,800
+875,405
+19% +$15.4M 0.18% 120
2016
Q2 		$56M Buy
4,571,395
+1,287,509
+39% +$9.7M 0.1% 231
2016
Q1 		$22.1M Buy
3,283,886
+1,397,086
+74% +$8.94M 0.04% 511
2015
Q4 		$17.4M Buy
1,886,800
+336,683
+22% +$3.13M 0.03% 696
2015
Q3 		$27.9M Buy
1,550,117
+1,008,170
+186% +$23.2M 0.04% 494
2015
Q2 		$16.1M Buy
541,947
+267,655
+98% +$6.72M 0.02% 722
2015
Q1 		$6.04M Buy
274,292
+257,748
+1,558% +$6.54M 0.01% 1257
2014
Q4 		$454K Sell
16,544
-412,636
-96% -$10M ﹤0.01% 3402
2014
Q3 		$8.32M Sell
429,180
-97,351
-18% -$1.78M 0.01% 1202
2014
Q2 		$8.97M Sell
526,531
-537,223
-51% -$7.4M 0.01% 1179
2014
Q1 		$15.1M Sell
1,063,754
-704,138
-40% -$9.51M 0.02% 807
2013
Q4 		$20.7M Sell
1,767,892
-152,706
-8% -$1.75M 0.03% 666
2013
Q3 		$22.7M Sell
1,920,598
-695,404
-27% -$8.92M 0.04% 530
2013
Q2 		$36.4M Buy
+2,616,002
New +$28.4M 0.07% 307

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

D.E. Shaw & Co's EXAS Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 502,142 shares — an estimated $51M sold.

D.E. Shaw & Co first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $216M in Q1 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 502,142 Exact Sciences shares in Q1 2026, an estimated $51M.
  • D.E. Shaw & Co first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • D.E. Shaw & Co's Exact Sciences position peaked at $216M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.